SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-008717
Filing Date
2022-01-13
Accepted
2022-01-13 16:39:58
Documents
13
Period of Report
2022-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d282880d8k.htm   iXBRL 8-K 29125
2 EX-99.1 d282880dex991.htm EX-99.1 26212
  Complete submission text file 0001193125-22-008717.txt   187959

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA chrs-20220109.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20220109_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20220109_pre.xml EX-101.PRE 11405
7 EXTRACTED XBRL INSTANCE DOCUMENT d282880d8k_htm.xml XML 3368
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 22529451
SIC: 2836 Biological Products, (No Diagnostic Substances)